Specification Perturbation Measures Fragility, Not Robustness: Preserving the p–fr–nb Distinction

Authors

  • Thomas F Heston Department of Family Medicine, University of Washington, Seattle, USA; Department of Medical Education and Clinical Sciences, Elson S. Floyd College of Medicine, Washington State University, Spokane, USA https://orcid.org/0000-0002-5655-2512

DOI:

https://doi.org/10.5281/zenodo.20149369

Keywords:

fragility index, minimum specification perturbation, neutrality boundary framework, statistical robustness, randomized controlled trial, evidence quality, p-fr-nb framework, clinical trial methodology

Abstract

The fragility index is increasingly recognized as insufficient for evaluating clinical trial evidence, and orthogonal companion metrics have been proposed across methodological traditions. A recent statistics preprint introduces Minimum Specification Perturbation as a robustness metric measuring how many analyst decisions must change to flip a confidence interval across zero. Under the Neutrality Boundary Framework's definitions, however, that construction is a fragility metric — a perturb-and-count algorithm that flips the significance classification, structurally analogous to the fragility index but in specification space rather than outcome space. The actual robustness axis is the geometric distance of the observed effect from the null parameter value, which is the role the Neutrality Boundary Framework occupies. Preserving the distinction between fragility and robustness preserves the orthogonality at the heart of the significance-fragility-robustness framework, the p-fr-nb triplet. This triplet of data analysis remains the foundation for complete statistical evidence in biomedical research.

References

1. Dang H, Pham L, Nguyen M. Minimum Specification Perturbation: Robustness as Distance-to-Falsification in Causal Inference [Internet]. arXiv; 2026 [cited 2026 May 12]. Available from: https://arxiv.org/abs/2605.01579 doi:10.48550/ARXIV.2605.01579

2. Heston TF. The Neutrality Boundary Framework: Quantifying Statistical Robustness Geometrically. arXiv. 2025 Nov 2;2511.00982. doi:10.48550/arXiv.2511.00982

3. Heston TF, King JM. Predictive power of statistical significance. World J Methodol. 2017 Dec 26;7(4):112–6. doi:10.5662/wjm.v7.i4.112

4. Cote MP, Lubowitz JH, Rossi MJ, Matzkin E. The Fragility Index Is Typically Misinterpreted and of Low Value: Clinical Trials Are Designed to Be Fragile. Arthrosc J Arthrosc Relat Surg. 2024 Nov 1;40(11):2635–7. doi:10.1016/j.arthro.2024.08.003

5. Heston TF. Significance, Fragility, and Robustness in Clinical Trials: Stratifying Statistical Evidence. Cureus. 2025 Dec 31;17(12). doi:10.7759/cureus.100494

6. Sharifan A, Harrod C, Dobrescu A, Gartlehner G. Reverse fragility index shows high fragility in Cochrane meta-analyses with P values between 0.05 and 0.20: A meta-epidemiological study. J Clin Epidemiol. 2026 Apr 21;0(0). doi:10.1016/j.jclinepi.2026.112285 PubMed PMID: 42025973.

Downloads

Published

2026-05-13

How to Cite

Heston, T. F. (2026). Specification Perturbation Measures Fragility, Not Robustness: Preserving the p–fr–nb Distinction. Internet Medical Journal, 1(1), e20149369. https://doi.org/10.5281/zenodo.20149369

Issue

Section

Articles

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.